Morgan Stanley’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.36M Sell
782,642
-81,469
-9% -$767K ﹤0.01% 3732
2025
Q1
$4.68M Buy
864,111
+118,716
+16% +$643K ﹤0.01% 3976
2024
Q4
$5.55M Sell
745,395
-1,070,859
-59% -$7.98M ﹤0.01% 3905
2024
Q3
$14.5M Sell
1,816,254
-436,543
-19% -$3.49M ﹤0.01% 3105
2024
Q2
$19.6M Buy
2,252,797
+910,682
+68% +$7.92M ﹤0.01% 2696
2024
Q1
$27.7M Sell
1,342,115
-1,295,679
-49% -$26.8M ﹤0.01% 2336
2023
Q4
$61M Buy
2,637,794
+2,500,973
+1,828% +$57.8M ﹤0.01% 2232
2023
Q3
$1.09M Buy
136,821
+49,397
+57% +$395K ﹤0.01% 4749
2023
Q2
$761K Sell
87,424
-1,915
-2% -$16.7K ﹤0.01% 4998
2023
Q1
$263K Buy
89,339
+64,854
+265% +$191K ﹤0.01% 5581
2022
Q4
$85.7K Buy
24,485
+14,442
+144% +$50.5K ﹤0.01% 6054
2022
Q3
$79K Sell
10,043
-1,668
-14% -$13.1K ﹤0.01% 6194
2022
Q2
$91K Buy
11,711
+2,463
+27% +$19.1K ﹤0.01% 6323
2022
Q1
$113K Sell
9,248
-10,645
-54% -$130K ﹤0.01% 6238
2021
Q4
$243K Buy
19,893
+13,713
+222% +$168K ﹤0.01% 5965
2021
Q3
$64K Sell
6,180
-10,564
-63% -$109K ﹤0.01% 6602
2021
Q2
$150K Buy
16,744
+13,734
+456% +$123K ﹤0.01% 6159
2021
Q1
$31K Buy
3,010
+1,000
+50% +$10.3K ﹤0.01% 6564
2020
Q4
$13K Sell
2,010
-13,575
-87% -$87.8K ﹤0.01% 6562
2020
Q3
$80K Sell
15,585
-18
-0.1% -$92 ﹤0.01% 5526
2020
Q2
$118K Buy
15,603
+1,530
+11% +$11.6K ﹤0.01% 5321
2020
Q1
$143K Sell
14,073
-21,833
-61% -$222K ﹤0.01% 5027
2019
Q4
$556K Buy
35,906
+6,607
+23% +$102K ﹤0.01% 4869
2019
Q3
$531K Buy
29,299
+1,787
+6% +$32.4K ﹤0.01% 4658
2019
Q2
$451K Sell
27,512
-4,807
-15% -$78.8K ﹤0.01% 4654
2019
Q1
$578K Buy
32,319
+4,886
+18% +$87.4K ﹤0.01% 4465
2018
Q4
$519K Hold
27,433
﹤0.01% 4758
2018
Q3
$979K Sell
27,433
-350
-1% -$12.5K ﹤0.01% 4558
2018
Q2
$577K Buy
27,783
+350
+1% +$7.27K ﹤0.01% 4996
2018
Q1
$335K Hold
27,433
﹤0.01% 5222
2017
Q4
$297K Hold
27,433
﹤0.01% 5259
2017
Q3
$329K Hold
27,433
﹤0.01% 5111
2017
Q2
$469K Hold
27,433
﹤0.01% 4839
2017
Q1
$471K Hold
27,433
﹤0.01% 4872
2016
Q4
$469K Hold
27,433
﹤0.01% 4973
2016
Q3
$826K Buy
27,433
+10
+0% +$301 ﹤0.01% 4171
2016
Q2
$776K Sell
27,423
-83
-0.3% -$2.35K ﹤0.01% 4158
2016
Q1
$737K Buy
27,506
+83
+0.3% +$2.22K ﹤0.01% 4176
2015
Q4
$1.32M Sell
27,423
-200
-0.7% -$9.64K ﹤0.01% 3840
2015
Q3
$1.01M Sell
27,623
-126
-0.5% -$4.59K ﹤0.01% 4100
2015
Q2
$1.05M Sell
27,749
-4,630
-14% -$175K ﹤0.01% 4164
2015
Q1
$1.28M Buy
32,379
+3,993
+14% +$158K ﹤0.01% 3945
2014
Q4
$1.17M Buy
28,386
+291
+1% +$12K ﹤0.01% 4026
2014
Q3
$1.24M Buy
28,095
+117
+0.4% +$5.17K ﹤0.01% 3857
2014
Q2
$1.21M Buy
27,978
+555
+2% +$24.1K ﹤0.01% 3902
2014
Q1
$1.13M Sell
27,423
-4
-0% -$164 ﹤0.01% 3888
2013
Q4
$1.09M Buy
27,427
+4
+0% +$159 ﹤0.01% 3874
2013
Q3
$1.13M Sell
27,423
-1
-0% -$41 ﹤0.01% 3699
2013
Q2
$1.06M Buy
+27,424
New +$1.06M ﹤0.01% 3686